---
search:
  boost: 3
---

# Antihistamines â€“ Second Generation

This is a subcategory of Respiratory Agents.

## Formulary

### Preferred

| Preferred                               | Generic Name                           | Quantity | Time (Days) |
|:----------------------------------------|:---------------------------------------|:--------:|:-----------:|
| Cetirizine Syr <sup>QL</sup>            |                                        |          |             |
| Cetirizine Tab <sup>QL</sup>            | Cetirizine HCI Tabs (all strengths)    |   102    |     102     |
| Cetirizine / Pseudoephedrine            |                                        |          |             |
| Loratadine Rapid Dissolve <sup>QL</sup> | Loratadine Rapidly ODT (all strengths) |   102    |     102     |
| Loratadine Syr <sup>QL</sup>            | Loratadine Syrup (all strengths)       |   1020   |     102     |
| Loratadine Tab <sup>QL</sup>            | Loratadine Tab (all strengths)         |   102    |     102     |
| Loratadine / Pseudoephedrine            |                                        |          |             |

### Non-Preferred

| Non-Preferred                     | Generic Name | Quantity | Time (Days) |
|:----------------------------------|:-------------|:--------:|:-----------:|
| Cetirizine Chewable <sup>AR</sup> |              |          |             |
| Clarinex-D                        |              |          |             |
| Desloratadine                     |              |          |             |
| Fexofenadine                      |              |          |             |
| Levocetirizine                    |              |          |             |

## Authorizations

**Length of Authorizations**: 365 Days

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Non-Preferred

Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response of at least **30 days** with at least **two different preferred** drugs
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

### Subsequent Authorization

Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring

**AR** - Cetirizine Chewables: a PA is required for patients 6 years and older

## Links

[Denial Language (Rph Use Only: Technicians CANNOT deny Prior Authorizations)](https://mygainwell-my.sharepoint.com.mcas.ms/:w:/r/personal/rachel_carpenter_gainwelltechnologies_com/_layouts/15/Doc.aspx?sourcedoc=%7B73347C85-1D40-4514-80E9-9628185B51B4%7D&file=Denial%20Language%20Updated%2001012024.docx&action=embedview&mobiledirect=true&wdStartOn=91){:target="_blank" rel="noopener"} 

[Criteria](https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=96){ :target="_blank" rel="noopener"}

[Preferred Drug List](https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20effective%2001.01.2024.pdf#page=30){ :target="_blank" rel="noopener"}

[Quantity Limit List](https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/Quantity%20Limits.pdf){ :target="_blank" rel="noopener"}
